Welcome to the Wilson Lab!

The Wilson Lab’s Mission is to advance understanding of and treatment for genetic causes of lung and liver disease. We focus primarily on chronic obstructive pulmonary disease (COPD) and its most common monogenic cause, alpha-1 antitrypsin deficiency (AATD), using patient-derived stem cells to model and understand disease mechanisms.


COVID-19 is a significant public health crisis. Click here to learn more about the Wilson Lab’s response to the virus on both clinical and basic research fronts, in collaboration with the CReM and other laboratories.

As supply shortages arise, Boston Medical Center is in need of personal protective equipment (PPE) donations, and urgently needs nasopharyngeal swabs to perform COVID-19 testing. Please reach out to those in your network who may know of supply stockpiles and make a donation!! Contact bmcneedsppe@gmail.com for questions or to coordinate a donation.


Click here to read about our research program!

Together with the rest of the CReM, we feature Open-Source Biology! Click for freely downloadable protocols or to access iPS cell lines through the CReM iPSC repository!

Interested in clinical care for alpha-1 antitrypsin deficiency? Click here to find our Alpha-1 Center!

Read about The Wilson Lab research program in Alpha-1-to-one magazine and BU Today.

The Wilson Lab has openings for postdoctoral fellows– highly qualified applicants are encouraged to contact Dr. Wilson for more information.